These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33847299)

  • 1. Neonates With SARS-CoV-2 Infection and Pulmonary Disease Safely Treated With Remdesivir.
    Saikia B; Tang J; Robinson S; Nichani S; Lawman KB; Katre M; Bandi S
    Pediatr Infect Dis J; 2021 May; 40(5):e194-e196. PubMed ID: 33847299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review on Remdesivir: A Broad-spectrum Antiviral Molecule for Possible COVID-19 Treatment.
    Khazir J; Maqbool T; Mir BA
    Mini Rev Med Chem; 2021; 21(17):2530-2543. PubMed ID: 33596800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 updates: Remdesivir (Veklury) in high-risk outpatients with COVID-19.
    Med Lett Drugs Ther; 2022 Feb; 64(1644):31-32. PubMed ID: 35171898
    [No Abstract]   [Full Text] [Related]  

  • 4. Remdesivir for patients with COVID-19.
    Wu PE; Morris AM
    CMAJ; 2021 Jan; 193(4):E125. PubMed ID: 33408097
    [No Abstract]   [Full Text] [Related]  

  • 5. Compassionate Use of Remdesivir in Children With Severe COVID-19.
    Goldman DL; Aldrich ML; Hagmann SHF; Bamford A; Camacho-Gonzalez A; Lapadula G; Lee P; Bonfanti P; Carter CC; Zhao Y; Telep L; Pikora C; Naik S; Marshall N; Katsarolis I; Das M; DeZure A; Desai P; Cao H; Chokkalingam AP; Osinusi A; Brainard DM; Méndez-Echevarría A
    Pediatrics; 2021 May; 147(5):. PubMed ID: 33883243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of an Immunocompromised Pediatric Patient With Multiple Hospitalizations for Symptomatic COVID-19.
    DeVine MN; Maxwell S; Haynes AS; MacBrayne CE; Boguniewicz J
    J Pediatr Hematol Oncol; 2022 Jan; 44(1):e293-e295. PubMed ID: 33235142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compassionate use of remdesivir in children with COVID-19.
    Méndez-Echevarría A; Pérez-Martínez A; Gonzalez Del Valle L; Ara MF; Melendo S; Ruiz de Valbuena M; Vazquez-Martinez JL; Morales-Martínez A; Remesal A; Sándor-Bajusz KA; Cabañas F; Calvo C
    Eur J Pediatr; 2021 Apr; 180(4):1317-1322. PubMed ID: 33200304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remdesivir: treatment of COVID-19 in special populations.
    Molaei E; Molaei A; Hayes AW; Karimi G
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3829-3855. PubMed ID: 38180557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remdesivir as a broad-spectrum antiviral drug against COVID-19.
    Hong YN; Xu J; Sasa GBK; Zhou KX; Ding XF
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):541-548. PubMed ID: 33506946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 1).
    Qaseem A; Yost J; Etxeandia-Ikobaltzeta I; Abraham GM; Jokela JA; Forciea MA; Miller MC; Humphrey LL; ; Centor RM; Andrews R; Haeme R; Kansagara DL; Marcucci M
    Ann Intern Med; 2021 Feb; 174(2):229-236. PubMed ID: 33017175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Not Available].
    Wu PE; Morris AM
    CMAJ; 2021 Apr; 193(14):E495-E496. PubMed ID: 33824151
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk factors for liver enzyme elevation with remdesivir use in the treatment of paediatric COVID-19.
    Jinda T; Mizuno S; Tatami S; Kasai M; Ishida T
    J Paediatr Child Health; 2024 Jul; 60(7):299-302. PubMed ID: 38818963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular Considerations of Remdesivir and Favipiravir in the Treatment of COVID-19.
    Shahrbaf MA; Tabary M; Khaheshi I
    Cardiovasc Hematol Disord Drug Targets; 2021; 21(2):88-90. PubMed ID: 34387172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxychloroquine and Remdesivir in COVID-19: A critical analysis of recent events.
    Dang A; Vallish BN; Dang S
    Indian J Med Ethics; 2020; V(3):202-207. PubMed ID: 33295289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compassionate use of remdesivir for treatment of severe coronavirus disease 2019 in pregnant women at a United States academic center.
    McCoy JA; Short WR; Srinivas SK; Levine LD; Hirshberg A
    Am J Obstet Gynecol MFM; 2020 Aug; 2(3):100164. PubMed ID: 32838267
    [No Abstract]   [Full Text] [Related]  

  • 16. Infant With SARS-CoV-2 Infection Causing Severe Lung Disease Treated With Remdesivir.
    Frauenfelder C; Brierley J; Whittaker E; Perucca G; Bamford A
    Pediatrics; 2020 Sep; 146(3):. PubMed ID: 32554811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remdesivir (GS-5734) in COVID-19 Therapy: The Fourth Chance.
    Moirangthem DS; Surbala L
    Curr Drug Targets; 2021; 22(12):1346-1356. PubMed ID: 33267759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of remdesivir in the treatment of acute SARS-CoV-2 infection in pediatric patients.
    Player B; Huppler AR; Pan AY; Liegl M; Havens PL; Ray K; Mitchell M; Graff K
    BMC Infect Dis; 2024 Sep; 24(1):987. PubMed ID: 39289614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remdesivir for the treatment of COVID-19 in pregnancy.
    Lampejo T
    J Med Virol; 2021 Jul; 93(7):4114-4119. PubMed ID: 33788273
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic dilemmas in addressing SARS-CoV-2 infection: Favipiravir versus Remdesivir.
    Negru PA; Radu AF; Vesa CM; Behl T; Abdel-Daim MM; Nechifor AC; Endres L; Stoicescu M; Pasca B; Tit DM; Bungau SG
    Biomed Pharmacother; 2022 Mar; 147():112700. PubMed ID: 35131656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.